Fusion Pharmaceuticals (FUSN) PT Raised to $16 at RBC Capital
Tweet
Share
E-mailGet Alerts FUSN Hot Sheet
Price: $21.55 --0%
Rating Summary:
1 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 13 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
RBC Capital analyst Gregory Renza raised the price target on Fusion Pharmaceuticals (NASDAQ: FUSN) to $16.00 (from $12.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
